Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 16.3B | 25.2B | 23.8B | 16.8B |
Cost of revenue | 11.0B | 19.8B | 18.6B | 12.3B |
Gross profit | 5.3B | 5.5B | 5.2B | 4.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.8B | 4.4B | -7.1B | 2.4B |
Operating income | 1.1B | 1.4B | 3.1B | 722M |
Non operating interest income | ||||
Income | 155M | 367M | -399M | 83M |
Expense | 562M | 561M | 537M | 495M |
Other income expense | — | — | — | — |
Pretax income | 695M | 947M | 2.9B | 227M |
Tax provision | 162M | 193M | 411M | 46M |
Net income | 533M | 754M | 2.5B | 181M |
Basic EPS | 0.2 | 0.2 | — | 0.0 |
Diluted EPS | 0.2 | 0.2 | — | 0.0 |
Basic average shares | 2.6B | 2.6B | — | 2.6B |
Diluted average shares | 2.6B | 2.6B | — | 2.6B |
EBITDA | 2.4B | 2.7B | 3.8B | 1.7B |
Net income from continuing op. | 533M | 754M | 2.5B | 181M |
Minority interests | -93M | -225M | -412M | -85M |
Preferred stock dividends | 0 | 0 | 0 | 0 |